New York judge blocks DOJ from obtaining medical records in child transgender procedures probe

A federal judge in New York issued a temporary restraining order barring the Department of Justice from accessing medical records of minors who underwent transgender procedures at federally funded hospitals, halting a DOJ investigation into potential healthcare fraud before investigators could review the files.

District Judge Katherine Polk Failla ruled last week that the hospitals had "demonstrated that they will suffer irreparable harm" without court intervention, The Center Square reported. The order restrains and enjoins the DOJ from "seeking, receiving, using, retaining, or disseminating any identifying or sensitive health information" of the plaintiff hospitals through the subpoenas at issue or "substantially similar administrative or grand jury subpoenas."

The DOJ had issued the subpoenas as part of what it described as "investigations into health care offenses related to gender-affirming medical care." The department declined to comment on the ruling.

What the ruling says, and what it blocks

Judge Failla's order cited concerns that the DOJ's subpoenas could run "afoul of constitutional protections" and risk breaches "of physician-patient confidentiality under New York law." The ruling effectively freezes the federal government's ability to examine how taxpayer-funded hospitals used public money to perform transgender interventions on children.

The specific hospitals named as plaintiffs were not identified in public reporting, though the case, filed as Coe v. Blanche, appears on the ACLU's document server, suggesting the civil liberties organization may be involved in the litigation.

Judge Failla's staff did not respond to a request for comment from The Center Square.

Conservative watchdogs push back hard

The ruling drew sharp criticism from organizations that have pressed for greater scrutiny of pediatric gender medicine. Dr. Kurt Miceli, chief medical officer at Do No Harm, a medical watchdog group, called the decision "troubling."

"It's troubling to see activist judges overlook children's safety in matters involving sex change interventions. Alongside concerns about the medical risks, the Department of Justice is investigating potential healthcare fraud and the off-label promotion of drugs such as puberty blockers. Courts should enforce accountability, not block a needed examination of how these interventions have been used on minors."

That last point, off-label promotion of puberty blockers, sits at the center of the DOJ's inquiry. Federal investigators want to know whether hospitals prescribed drugs for purposes the FDA never approved, and whether billing practices around those prescriptions crossed legal lines. Judge Failla's order now prevents investigators from reviewing the very records that could answer those questions.

The pattern of federal judges blocking administration policy actions has become a recurring flashpoint in the broader legal landscape, and this case adds another front to that conflict.

Hospitals and taxpayer dollars

Will Hild, executive director of Consumers' Research, framed the hospitals' legal fight as an extension of institutional resistance to oversight. He told The Center Square that his organization had already exposed nonprofit hospitals, including Mount Sinai, for what he described as misuse of their tax-exempt status.

"We have already exposed nonprofit hospitals, like Mount Sinai, for using taxpayer dollars and tax-exempt status while abandoning their core patient care mission in favor of radical ideological agendas. These systems and their constant pushback against transparency and accountability only further raises questions of potential misuse of taxpayer dollars."

Hild added that "it is not shocking that these nonprofit hospitals will stop at nothing to continue their woke policies," but credited the Trump administration with forcing a reckoning. "Thanks to the Trump administration, these hospitals are finally facing accountability," he said.

The tension between hospital systems and federal investigators raises a straightforward question: if these institutions receive federal funding, why should they be shielded from federal review? Physician-patient confidentiality is a serious legal protection. But confidentiality was designed to protect patients, not to insulate institutions from fraud investigations.

DOJ's track record in Texas and Ohio

The New York ruling stands in contrast to the DOJ's recent wins elsewhere. Earlier in June, the Cleveland Clinic Foundation reached an agreement with the Justice Department to provide detransition care and stop performing what the DOJ called "sex-rejecting procedures on minors." That agreement followed a similar deal with Texas Children's Hospital.

Terry Schilling, president of the American Principles Project, pointed to those settlements as evidence that the DOJ's approach is working, when courts don't intervene to stop it. As questions about DOJ funding and anti-weaponization efforts continue to simmer on Capitol Hill, the New York case adds new urgency to the debate over how far federal law enforcement can reach.

"The Trump administration has won historic victories against hospital systems that profited from the misery of confused minors in both Texas and Ohio. The doctors and institutions that failed to protect patients and vulnerable families may try to dodge accountability and scrutiny, but justice is coming for children and detransitioners."

Two major hospital systems agreed to change course voluntarily. In New York, a federal judge decided the DOJ shouldn't even be allowed to look at the records.

The accountability gap

The core issue here is not abstract. Federally funded hospitals performed medical interventions on children. The DOJ wants to determine whether those interventions involved fraud, off-label drug promotion, or other healthcare offenses. A judge has now told investigators they cannot review the evidence.

The ruling is temporary, a restraining order, not a final judgment. But temporary orders have a way of setting the trajectory for litigation. And the longer investigators are locked out of these records, the harder it becomes to build any case at all.

The broader pattern of courts shaping the boundaries of executive authority is playing out across multiple fronts. In this instance, the question is whether a single district judge can wall off an entire category of federal investigation by invoking state confidentiality law against a federal subpoena.

Meanwhile, the children at the center of this dispute, the minors whose medical records the DOJ sought, remain voiceless in the legal fight. The hospitals claim to be protecting them. The DOJ claims to be investigating on their behalf. And a federal judge has decided, for now, that the hospitals' position wins.

Accountability efforts that face resistance from the institutions under scrutiny are nothing new. The question of whether political actors use procedural tools to shield allies from oversight runs through many of the legal battles playing out in Washington and beyond.

What comes next

The DOJ has not commented on whether it will appeal the restraining order or seek to have it modified. The case name visible in court filings, Coe v. Blanche, suggests the litigation is still in its early stages. Several open questions remain: which hospitals are involved, what specific subpoenas were issued, and what constitutional provisions the court believes are at stake.

The Cleveland Clinic and Texas Children's Hospital agreements show what cooperation looks like. New York's courtroom standoff shows what resistance looks like. The difference matters, because somewhere in those sealed records are the medical histories of children whose families trusted these institutions to do right by them.

When hospitals fight harder to keep investigators out than to prove they did nothing wrong, taxpayers and parents are entitled to wonder what exactly is in those files.